caffeic acid phenethyl ester has been researched along with ALS - Amyotrophic Lateral Sclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbott, BM; Browne, EC | 1 |
| Du, Y; Farlow, MR; Fontanilla, CV; Johnstone, B; Pascuzzi, RM; Wei, X; Zhao, L | 1 |
1 review(s) available for caffeic acid phenethyl ester and ALS - Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Recent progress towards an effective treatment of amyotrophic lateral sclerosis using the SOD1 mouse model in a preclinical setting.
Topics: Amyotrophic Lateral Sclerosis; Animals; Biological Products; Disease Models, Animal; Drug Discovery; Humans; Mice; Superoxide Dismutase-1 | 2016 |
1 other study(ies) available for caffeic acid phenethyl ester and ALS - Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Caffeic acid phenethyl ester extends survival of a mouse model of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Anti-Inflammatory Agents, Non-Steroidal; Caffeic Acids; Disease Models, Animal; Female; Humans; Male; Mice; Mice, Transgenic; Neuroprotective Agents; Phenylethyl Alcohol; Survival Rate; Treatment Outcome | 2012 |